Monte Rosa Therapeutics, Inc. (GLUE)

Monte Rosa Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	78.53	224.25	128.1	54.91	346.07	41.7
Short-Term Investments	247.54	147.9	104.31	207.91	-	-
Cash & Short-Term Investments	326.07	372.15	232.41	262.83	346.07	41.7
Cash Growth	69.05%	60.12%	-11.57%	-24.05%	729.93%	595.56%
Other Receivables	1.41	0.17	0.51	7.66	-	0.1
Receivables	1.41	0.17	0.51	7.66	-	0.1
Prepaid Expenses	4.8	5.12	3.29	4.44	2.6	1.79
Restricted Cash	-	-	-	0.96	-	-
Total Current Assets	332.28	377.44	236.21	275.89	348.67	43.59
Property, Plant & Equipment	55.6	56.31	62.61	61.91	12.33	4.62
Other Long-Term Assets	5.32	4.98	4.93	4.6	5.34	1.16
Total Assets	393.2	438.73	303.76	342.39	366.33	49.38
Accounts Payable	6.49	17.22	11.15	7.86	6.56	7.07
Accrued Expenses	11.87	15.43	12.93	9.56	9.24	1.13
Current Portion of Leases	3.87	3.71	3.16	3.13	-	-
Current Unearned Revenue	32.58	117.23	17.68	-	-	-
Other Current Liabilities	4.42	3.35	1.67	5.02	0.84	21.08
Total Current Liabilities	59.22	156.95	46.59	25.57	16.64	29.28
Long-Term Leases	38	39	42.88	43.87	-	-
Long-Term Unearned Revenue	16.86	16.15	32.32	-	-	-
Total Liabilities	118.04	215.8	124.51	70.98	18.81	30.34
Common Stock	0.01	0.01	0.01	0.01	0.01	0
Additional Paid-In Capital	670.19	664.87	547.86	503.7	471.57	0.4
Retained Earnings	-391.7	-438.59	-365.89	-230.54	-122.04	-48.08
Comprehensive Income & Other	-3.33	-3.36	-2.72	-1.75	-2.02	-1.06
Total Common Equity	275.16	222.94	179.25	271.41	347.52	-48.73
Shareholders' Equity	275.16	222.94	179.25	271.41	347.52	19.04
Total Liabilities & Equity	393.2	438.73	303.76	342.39	366.33	49.38
Total Debt	41.86	42.72	46.04	47	-	-
Net Cash (Debt)	284.21	329.43	186.37	215.83	346.07	41.7
Net Cash Growth	92.41%	76.76%	-13.65%	-37.64%	729.93%	695.02%
Net Cash Per Share	3.57	4.46	3.63	4.57	13.84	27.49
Filing Date Shares Outstanding	61.51	61.51	50.14	49.24	46.37	1.69
Total Common Shares Outstanding	61.51	61.51	50.14	49.32	46.54	1.69
Working Capital	273.06	220.49	189.62	250.32	332.03	14.32
Book Value Per Share	4.47	3.62	3.57	5.50	7.47	-28.91
Tangible Book Value	275.16	222.94	179.25	271.41	347.52	-48.73
Tangible Book Value Per Share	4.47	3.62	3.57	5.50	7.47	-28.91
Machinery	27.77	27.4	24.23	18.65	13.06	5.23
Construction In Progress	0.48	0.06	0.92	12.01	0.85	-
Leasehold Improvements	22.39	22.39	20.89	2.66	1.12	-

Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q